14 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
. The base salary payable to each NEO is intended to provide a fixed component of compensation reflecting the NEO’s skill set, experience, role
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
,” information that was or is deemed available to a person of skill in the relevant art prior to the priority date of the claimed invention. There may be prior
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
of our inventions depends on the scope and content of the “prior art,” information that was or is deemed available to a person of skill in the relevant … . The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive’s skill
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
of skill in the relevant art prior to the priority date of the claimed invention. There may be prior art of which we are not aware that may affect … the executive’s skill set, experience, role and responsibilities.
For 2022, Mr. Berns, Dr. Pinto and Dr. Dunlop had an annual base salary of $570,000
S-1
s30 tfzdofhis
25 Aug 23
IPO registration
5:03pm
DRS/A
hemx4lu97ct
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
yeh1s3 xss6crynheo3
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
mxar4l
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
yhw2q2
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
xs3jhl103ws4fhbexq0
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
r04jbs
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
vb4h19wj
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
cvy pq47v5tgsh3ljvx
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next